-
FPL-55712
- names:
7-[3-(4-Acetyl-3-hydroxy-2-propylphenoxy)-2-hydroxypropoxy]- 4-oxo-8-propyl-4H-1-benzopyran-2-carboxylic acid sodium salt
- CAS号:
40786-08-1
MDL Number: - MF(分子式): C27H29NaO9 MW(分子量): 520.5098
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
|---|
| 中文别名 | FPL-55712 |
| 英文别名 | FPL-55712; FPL55712; FPL 55712 |
| CAS号 | 40786-08-1 |
| Inchi | InChI=1S/C27H30O9.Na/c1-4-6-19-22(10-8-17(15(3)28)25(19)31)34-13-16(29)14-35-23-11-9-18-21(30)12-24(27(32)33)36-26(18)20(23)7-5-2;/h8-12,16,29,31H,4-7,13-14H2,1-3H3,(H,32,33);/q;+1/p-1 |
| InchiKey | ZDEVPOBNLIVGFA-UHFFFAOYSA-M |
| 分子式 Formula | C27H29NaO9 |
| 分子量 Molecular Weight | 520.5098 |
| 溶解度Solubility | |
| 性状 | Solid powder |
| 储藏条件 Storage conditions | Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years). |
| 产品说明 | FPL-55712(CAS:40786-08-1):仅限应用于工业或者科学研究过程中非医疗目的,不应用于人类或动物的临床诊断以及治过程疗,该产品非药用,非食用。 |
| Introduction | FPL-55712 is a CysLT1 leukotriene receptor antagonist. |
| Application1 | |
| Application2 | |
| Application3 |
| [1]Busch L, Miozza V, Sterin-Borda L, Borda E. Increased leukotriene concentration in submandibular glands from rats with experimental periodontitis. Inflamm Res. 2009 Jul;58(7):423-30. doi: 10.1007/s00011-009-0008-8. Epub 2009 Apr 4. PubMed PMID: 19347252. |
| [2]Montuschi P. Leukotrienes, antileukotrienes and asthma. Mini Rev Med Chem. 2008 Jun;8(7):647-56. Review. Erratum in: Mini Rev Med Chem. 2008 Sep;8(10):1064. PubMed PMID: 18537720. |
| [3] Buccellati C, Fumagalli F, Viappiani S, Folco G. Leukotriene modifiers: novel therapeutic opportunities in asthma. Farmaco. 2002 Mar;57(3):235-42. Review. PubMed PMID: 11989802. |
| [4] Young RN. Discovery of montelukast: a once-a-day oral antagonist of leukotriene D4 for the treatment of chronic asthma. Prog Med Chem. 2001;38:249-77. Review. PubMed PMID: 11774796. |
| [5] Lai YL, Lee CF. Mediators and oxygen radicals in hyperpnea-induced airway constriction of guinea pigs. Lung. 2000;178(4):213-23. PubMed PMID: 10960556. |
6: Hamanaka N, Nakai H. [Leukotriene D4 antagonists]. Tanpakushitsu Kakusan Koso. 2000 Apr;45(6 Suppl):967-72. Review. Japanese. PubMed PMID: 10771659.7: Lai YL, Lee SP. Mediators in hyperpnea-induced bronchoconstriction of guinea pigs. Naunyn Schmiedebergs Arch Pharmacol. 1999 Nov;360(5):597-602. PubMed PMID: 10598800.8: Nicosia S. Pharmacodynamic properties of leukotriene receptor antagonists. Monaldi Arch Chest Dis. 1999 Jun;54(3):242-6. Review. PubMed PMID: 10441979.9: Takami M, Tsukada W. In vitro effect of DP-1904, a novel anti-asthma agent, against antigen-induced constriction and TXB2 release from the isolated guinea-pig lung parenchymal tissue. Pharmacol Res. 1998 Aug;38(2):141-7. PubMed PMID: 9721602.10: Marcelle R. Leukotrienes antagonist-inhibitor and the bronchial response to inhaled antigen in actively sensitized guinea-pigs. Arch Physiol Biochem. 1998 Aug;105(4):358-64. PubMed PMID: 9711356.1
对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
抱歉,暂无数据!


购物车 


